Literature DB >> 10640751

The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses.

R B Clark1, D Bishop-Bailey, T Estrada-Hernandez, T Hla, L Puddington, S J Padula.   

Abstract

The peroxisome proliferator-activated receptors (PPARs) are a family of transcription factors belonging to the nuclear receptor superfamily. Until recently, the genes regulated by PPARs were those believed to be predominantly associated with lipid metabolism. Recently, an immunomodulatory role for PPAR gamma has been described in cells critical to the innate immune system, the monocyte/macrophage. In addition, evidence for an antiinflammatory role of the PPAR gamma ligand, 15-deoxy-Delta 12,14-PGJ2 (15d-PGJ2) has been found. In the present studies, we demonstrate, for the first time, that murine helper T cell clones and freshly isolated splenocytes express PPAR gamma 1. The PPAR gamma expressed is of functional significance in that two ligands for PPAR gamma, 15d-PGJ2 and a thiazolidinedione, ciglitazone, mediate significant inhibition of proliferative responses of both the T cell clones and the freshly isolated splenocytes. This inhibition is mediated directly at the level of the T cell and not at the level of the macrophage/APC. Finally, we demonstrate that the two ligands for PPAR gamma mediate inhibition of IL-2 secretion by the T cell clones while not inhibiting IL-2-induced proliferation of such clones. The demonstration of the expression and function of PPAR gamma in T cells reveals a new level of immunoregulatory control for PPARs and significantly increases the role and importance of PPAR gamma in immunoregulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640751     DOI: 10.4049/jimmunol.164.3.1364

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  136 in total

1.  Dietary supplementation with conjugated linoleic acid does not alter the resistance of mice to Listeria monocytogenes infection.

Authors:  L Turnock; M Cook; H Steinberg; C Czuprynski
Journal:  Lipids       Date:  2001-02       Impact factor: 1.880

Review 2.  Peroxisome proliferator activated receptor gamma: a potential therapeutic target in the management of ischaemic heart disease.

Authors:  J S Sidhu; J C Kaski
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

3.  15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.

Authors:  Priyadarshini Raman; Barbara L F Kaplan; Jerry T Thompson; John P Vanden Heuvel; Norbert E Kaminski
Journal:  Mol Pharmacol       Date:  2011-04-21       Impact factor: 4.436

4.  Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.

Authors:  Hulya Yilmaz-Aydogan; Ozlem Kurnaz; Ozlem Kurt; Basak Akadam-Teker; Ozlem Kucukhuseyin; Atike Tekeli; Turgay Isbir
Journal:  Mol Cell Biochem       Date:  2011-07-21       Impact factor: 3.396

Review 5.  Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease.

Authors:  Josep Bassaganya-Riera; Raquel Hontecillas
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-09       Impact factor: 4.294

6.  Phosphatase and tensin homolog-β-catenin signaling modulates regulatory T cells and inflammatory responses in mouse liver ischemia/reperfusion injury.

Authors:  Qiang Zhu; Changyong Li; Kunpeng Wang; Shi Yue; Longfeng Jiang; Michael Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Feng Zhang; Ling Lu; Bibo Ke
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

7.  VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways.

Authors:  Carmen Del Rio; Irene Cantarero; Belén Palomares; María Gómez-Cañas; Javier Fernández-Ruiz; Carolina Pavicic; Adela García-Martín; Maria Luz Bellido; Rafaela Ortega-Castro; Carlos Pérez-Sánchez; Chary López-Pedrera; Giovanni Appendino; Marco A Calzado; Eduardo Muñoz
Journal:  Br J Pharmacol       Date:  2018-08-23       Impact factor: 8.739

8.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.

Authors:  Andrew C Li; Christoph J Binder; Alejandra Gutierrez; Kathleen K Brown; Christine R Plotkin; Jennifer W Pattison; Annabel F Valledor; Roger A Davis; Timothy M Willson; Joseph L Witztum; Wulf Palinski; Christopher K Glass
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

9.  Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma.

Authors:  Nicholas P Evans; Sarah A Misyak; Eva M Schmelz; Amir J Guri; Raquel Hontecillas; Josep Bassaganya-Riera
Journal:  J Nutr       Date:  2010-01-20       Impact factor: 4.798

10.  Nutritional effects on host response to lung infections with mucoid Pseudomonas aeruginosa in mice.

Authors:  Anna M van Heeckeren; Mark Schluchter; Lintong Xue; Juan Alvarez; Steven Freedman; Judith St George; Pamela B Davis
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.